Compare LNTH & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | MIR |
|---|---|---|
| Founded | 1956 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.6B |
| IPO Year | 2014 | N/A |
| Metric | LNTH | MIR |
|---|---|---|
| Price | $95.42 | $18.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $87.00 | $27.25 |
| AVG Volume (30 Days) | 765.0K | ★ 3.4M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $343,374,000.00 | N/A |
| Revenue This Year | N/A | $23.95 |
| Revenue Next Year | $14.19 | $7.32 |
| P/E Ratio | ★ $53.29 | $195.00 |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $47.27 | $16.43 |
| 52 Week High | $95.98 | $30.28 |
| Indicator | LNTH | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 75.76 | 44.16 |
| Support Level | $72.35 | $16.98 |
| Resistance Level | N/A | $20.70 |
| Average True Range (ATR) | 2.94 | 0.96 |
| MACD | 0.96 | -0.06 |
| Stochastic Oscillator | 96.97 | 49.75 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.